title: Preclinical wound-healing studies with recombinant human basic fibroblast growth factor.
authors.affiliation: California Biotechnology, Inc., Mountain View 94043.
authors.forename: J C
authors.initials: JC
authors.lastname: Fiddes
authors.forename: P A
authors.initials: PA
authors.lastname: Hebda
authors.forename: P
authors.initials: P
authors.lastname: Hayward
authors.forename: M C
authors.initials: MC
authors.lastname: Robson
authors.forename: J A
authors.initials: JA
authors.lastname: Abraham
authors.forename: C K
authors.initials: CK
authors.lastname: Klingbeil
mesh_terms: D000287:Administration, Topical; D000818:Animals; D001424:Bacterial Infections / Q000473:pathology; D003921:Diabetes Mellitus, Experimental / Q000473:pathology; D016222:Fibroblast Growth Factor 2 / Q000494:pharmacology*; D006099:Granuloma / Q000473:pathology; D051379:Mice; D008817:Mice, Mutant Strains; D051381:Rats; D011994:Recombinant Proteins / Q000494:pharmacology; D012867:Skin / Q000473:pathology; D013552:Swine; D013630:Tampons, Surgical; D014945:Wound Healing
chemical_list: D011994:Recombinant Proteins; D016222:Fibroblast Growth Factor 2